Programmed intermittent bolus infusion versus continuous infusion of 0.2% ropivacaine after ultrasound-guided continuous interscalene brachial plexus block in arthroscopic shoulder surgery

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0005197

Enrollment

Registered

2020-07-02

Start date

2020-12-21

Completion date

Unknown

Last updated

2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Procedure/Surgery : Ultrasound-guided continuous interscalene brachial plexus block is performed on patients undergoing arthroscopic shoulder surgery. After the procedure, the programmed portable elec

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: American Society of Anesthesiology physical status I-III patients scheduled for arthroscopic shoulder surgery

Exclusion criteria

Exclusion criteria: Patients who lack the ability to understand or perform the test in this study, patients with deficiency of blood clotting, patients with brachial plexus lesions, those with neurological defects at the treatment site, allergic reactions to ropivacaine in previous surgery or procedures, and pregnant women are excluded.

Design outcomes

Primary

Measure	Time frame
Postoperative pain using visual analgue scale	—

Secondary

Measure	Time frame
Total amount and numbers of additional analgesics administered 48 hours after leaving the post-anesthetic care unit;Modified Bromage scale of upper extremities muscles;Patient satisfaction of postoperative pain control;Analyzing the usage pattern of portable electronic injection pump (total dose, frequency of bolus injection, night dose)	—

Countries

Korea, Republic of

Contacts

Public ContactGyeong-Jo Byeon

Pusan National University Yangsan Hospital

cooki1713@naver.com+82-55-360-2758

Outcome results